Clinical practice considerations in facioscapulohumeral muscular dystrophy Sydney, Australia, 21 September 2015

- Best practice molecular diagnostic reference standards require international collaboration.
- Information on lifestyle management, physical therapy and bone health were provided.
- Respiratory and extramuscular complications and options for palliative therapy were discussed.
- Potential investigative disease-modifying agents for FSHD were identified.
- The role and requirements for FSHD registries were explored.